from ChAT(BAC)-eGFP mice. The enriched CD4 + cell suspension was then stained with anti-CD62L PE-Cy7 (eBioscience) and anti-CD19 APC (BD Biosciences) antibodies. After gating out CD19 + and CD62L high cells, a ChAT-eGFP -and a ChAT-eGFP + fraction were collected using a FACSAria cell sorter (Becton Dickinson 
Spleen lymphocyte and T cell culture for acetylcholine determination
Total spleen cell suspensions were obtained from BALB/c mice. Cells were incubated for 2 hours in complete RPMI medium at 37°C. Non-adherent cells were collected and washed once in PBS, and incubated in 96-well plates in PBS for 15 min at 37°C in the presence or absence of norepinephrine (Sigma-Aldrich ChAT-eGFP + were incubated in PBS for 15 min at 37°C. Cells were spun down and supernatants were kept frozen at -80°C. Acetylcholine was determined by mass spectrometry. ChAT-eGFP + cells obtained by cell sorting were incubated in complete RPMI medium in 96-well plates in the presence or absence of plate-bound anti-CD3 antibody (10 μg/mL) (clone 145-2C11, BD Biosciences) for 48 hours. ChAT-eGFP expression was then determined by flow cytometry. Cytokine levels were determined by cytometric bead array immunoassay using the mouse Th1/Th2/Th17 cytokine kit (BD Biosciences).
T cell stimulation and quantification of cytokine production

Adrenergic receptor mRNA quantification
Total RNA was extracted from spleen CD4 + ChAT-eGFP + cells (obtained by cell sorting, see above) and mouse cardiomyocytes (used as positive control for adrenergic receptors β 1, β 2, and β 3 ) using the RNeasy Mini Kit (Qiagen), including on-column DNase treatment (Qiagen), and reverse transcribed to cDNA using iScript cDNA synthesis kit (Biorad). Semi-quantitative measurements of mRNA levels were obtained using the reaction mix Light Cycler 480 Probes Master (Roche) in the LightCycler 480 System (Roche) using the following primers (Invitrogen) and probes (Roche Universal Probe Library): Adrb1, left 5´-cctagagggcaaaccttgtg-3´, right 5´-tgcacagagtgaggtagaggac-3´, probe #18; Adrb2, left 5´-cgagctgagtgtgcaggac-3´, right 5´-gactcctggaagcttcattca-3´, probe #76; Adrb3, left 5´-cagccagccctgttgaag-3´, right 5´-ccttcatagccatcaaacctg-3´, probe #13; Actb, left 5'-cgtgaaaagatgacccagatca-3', right 5'-tggtacgaccagaggcatacag-3', probe 5'-tcaacaccccagccatgtacgtagcc-3'. Values were calculated from a standard curve and β-actin was used as reference gene. ChAT-eGFP + cells were labeled with CellTrace Violet (Invitrogen). Briefly, cells (10 6 cells/mL) were incubated in PBS containing CellTrace Violet (100nM) for 30 min at 37°C. Cells were then resuspended in complete medium and incubated for 30 min at 37°C. Cells were washed and transferred to nude mice (2 x 10 6 /50 μL of sterile PBS). Total spleen cells were analyzed by flow cytometry for eGFP and CellTrace Violet fluorescence five days later. In another set of experiments, an enriched suspension of CD4 + T cells (purity >90%) was obtained from mouse spleens by negative selection using magnetic columns (CD4 + T cell Isolation kit II, Miltenyi). A pool of siRNAs directed against ChAT (s63922, s63923, s63924, Ambion) or scrambled siRNA (4390843, Ambion) at 300 nM was electroporated into the cells using the Amaxa Mouse T cell Nucleofection kit (Lonza) and kept in culture. One day later, cells were transferred to BALB/c nude mice (2.5 x 10 5 cells/200 μL of sterile PBS). Three days later, mice were subjected to vagus nerve stimulation and endotoxemia. ChAT expression levels were investigated at day 4 by protein immunoblot of transfected cells kept in culture.
Adoptive transfer
CD4
Protein immunoblot
Protein was obtained using the protein extraction reagent (T-PER, ThermoScientific) containing protease inhibitors (MiniPREP, Roche). SDS protein electrophoresis and immunoblot were performed using a standard protocol. Antibodies used were rabbit anti-choline acetyltransferase (Pierce) and mouse anti-β-actin (Novus Biologicals). Secondary antibodies were detected using goat anti-rabbit IRDye 680 (Licor), and goat anti-mouse IRDye800 (Licor). Blotting was visualized using the Odyssey infrared imaging system (Licor).
Vagus nerve stimulation
Mice were anesthetized with ketamine (100 mg/kg) and xylazine (10 mg/kg), i.p. A midline cervical incision was made and the left cervical vagus nerve was isolated and placed on a bipolar platinum electrode (Plastics One). Electrical stimulation was delivered at 1 V, 2 ms, 5 Hz for 2.5 min by a stimulation module (STM100A) controlled by the AcqKnowledge software (Biopac Systems). In sham-operated animals only a cervical incision was made. Two hours after vagus nerve stimulation, endotoxin (LPS from Escherichia coli, 0111:B4; Sigma) was injected (10 mg/kg, i.p.). Mice were euthanized 90 min later and serum was obtained for determination of TNF, IL-6 and IL-10 concentration by ELISA (R&D Systems) or by cytometric bead array immunoassay using the mouse Th1/Th2/Th17 cytokine kit (BD Biosciences 
Microdialysis
BALB/c mice were anesthesized with urethane (2 g/kg) and xylazine (8 mg/kg), i.p., and placed on a heating pad. A 1 cm-long incision was made in the left flank to expose the spleen. A linear probe (BASi) containing a dialysis membrane (diameter 360 μm, 5 mm-long) was inserted parallel to the longitudinal axis of the spleen through a 25 gauge needle. After removing the needle, the spleen was returned to the abdominal cavity and the skin was sutured. Ringer's solution (Baxter) without acetylcholinesterase inhibitors was perfused with a syringe pump (Harvard Aparatus) at a constant flow rate of 1 μL/min. Sample collection started 30 min after probe insertion, allowing for dialysis membrane activation. Samples were collected every 10 min until the end of the experiment. Baseline acetylcholine release was determined in 3 samples collected prior to any surgical manipulation of the vagus nerve. The vagus nerve was stimulated for 5 min at 5 V, 2 ms, and 5 Hz.
Acetylcholine quantification
Acetylcholine concentration was determined by chromatography followed by mass spectrometry. Chromatographic separation was achieved using an Aquity BEH C18 column (2.1x50 mm, 1.7 μm; Waters Corporation) which was maintained at oven temperature of 25ºC. Pumping was performed by using the UPLC system (Waters) at a flow rate of 0.5 mL/min. Samples were loaded in the Waters Aquity UPLC autosampler. Temperature of the autosampler was set at 10ºC. 5 μL of sample extract was injected and the eluent was monitored by tandem mass spectrometry with an electrospray ionization (ESI) interface of Vantage Triple Quadrupole mass spectrometer (Thermo). The chromatographic data was acquired and processed using the Xcalibur software Version 3.07. The positive ions were monitored in the multiple reaction monitoring (MRM) mode. The following ion transitions (m/z) were monitored: 146.0 (parent) and 87.0 (product) for acetylcholine and 150.0 (parent) and 91.0 (product) for 1,1,2,2-acetylcholine-D4 that was used as the internal standard.
Statistical analysis
Data are expressed as mean ± SEM. Differences between means were determined using twotailed t test or ANOVA with repeated measures using the Dunnett post hoc test. P values < 0.05 were considered significant. + cells transfected with ChAT siRNA were subjected to sham surgery or vagus nerve stimulation followed by endotoxin injection. Serum IL-6 (A) and IL-10 (B) were determined 90 minutes after endotoxin administration. Results are expressed as mean ± SEM. * P < 0.05 compared to the respective sham group (twotailed t test). 
